Effect of COVID-19 on Hematological Malignancies

Effect of COVID-19 on Hematological Malignancies

Patients with hematological malignancies face unique infectious risks and the COVID-19 pandemic has understandably shaken this community. Knowledgeable and experienced subject matter experts have joined with the IMANA Education Committee to present an informative webinar outlining the outcomes of patients with hematological malignancies. We are proud to have Dr. Maria Chaudhry present on multiple myeloma, Dr. Seema A. Bhat present on the effect of COVID-19 on Hematological malignancies. Register: https://learn.imana.org/hematologic-malignancies